EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Single-Cell RNA-Seq Revealed the Immune Microenvironment Reprogramming by Dexmedetomidine Treatment in Ischemic Stroke

Wenyi Zhang, Xingyun Wang, Bing Zhang, Minjiang Yi, Yinzhong Lu, Shuyan Wang, Junfeng Zhang, Guangming Zhang

Molecular Neurobiology · 2025

DOI: 10.1007/s12035-025-05237-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Wenyi Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China. Hauptthemen laut MEDLINE: Dexmedetomidine, Ischemic Stroke, Single-Cell Analysis, RNA-Seq. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Anesthesiology and Critical Care Medicine Master and Doctor Innovation Talent Base Fundation of Changning District, Shanghai Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prior studies have indicated that the neuroprotective effects of dexmedetomidine (DEX) in cerebral ischemia, yet its mechanisms remain elusive. Using multi-omics approaches (RNA-seq, metabolomics, and single-cell RNA-seq), we discovered that DEX pretreatment significantly reduced cerebral infarct volume and improved neurological function in middle cerebral artery occlusion (MCAO) mice compared to PBS controls. Single-cell analysis revealed that DEX preserved microglial phagocytic function via metabolic regulation, leading to reduced microglial apoptosis and attenuated immune dysregulation-including decreased chemotactic neutrophils, B cells, and antigen-presenting fibroblasts. These cellular changes were corroborated by transcriptomic and metabolic profiles showing suppressed apoptosis and inflammation. Mechanistically, we identified HK2 (hexokinase 2) as a key regulator of microglial homeostasis, with its expression correlating with microglial migration, proliferation, and inflammation, findings validated in oxygen-glucose deprivation models. Collectively, our results demonstrate that DEX protects against cerebral ischemia-reperfusion injury by maintaining immune microenvironment homeostasis through microglial metabolic reprogramming mediated by HK2. This multi-omics study provides mechanistic insights supporting DEX's translational potential in ischemic stroke therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidineIschemic StrokeSingle-Cell AnalysisRNA-SeqCellular MicroenvironmentAnimalsMicrogliaMice, Inbred C57BLMaleMiceApoptosisInfarction, Middle Cerebral ArteryNeuroprotective AgentsSingle-Cell Gene Expression Analysis

Stichwörter der Autor:innen

ApoptosisDexmedetomidineMCAOScRNA-seqStroke

Substanzen

DexmedetomidineNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.
  • Department of Anesthesiology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, China.
  • Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.
  • Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China. Wsy2785@shtrhospital.com.
  • Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China. zhangjunfeng@sjtu.edu.cn.
  • Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China. gmzhangyj@126.com.

Förderung

  • National Natural Science Foundation of China
  • Anesthesiology and Critical Care Medicine Master and Doctor Innovation Talent Base Fundation of Changning District
  • Shanghai Natural Science Foundation

Zitieren

APA

Zhang, W., Wang, X., Zhang, B., Yi, M., Lu, Y., Wang, S., Zhang, J., & Zhang, G. (2025). Single-Cell RNA-Seq Revealed the Immune Microenvironment Reprogramming by Dexmedetomidine Treatment in Ischemic Stroke. Molecular Neurobiology. https://doi.org/10.1007/s12035-025-05237-1

Vancouver

Zhang W, Wang X, Zhang B, Yi M, Lu Y, Wang S, et al. Single-Cell RNA-Seq Revealed the Immune Microenvironment Reprogramming by Dexmedetomidine Treatment in Ischemic Stroke. Molecular Neurobiology. 2025. doi:10.1007/s12035-025-05237-1

BibTeX
@article{Zhang2025,
  author = {Zhang, Wenyi and Wang, Xingyun and Zhang, Bing and Yi, Minjiang and Lu, Yinzhong and Wang, Shuyan and Zhang, Junfeng and Zhang, Guangming},
  title = {Single-Cell RNA-Seq Revealed the Immune Microenvironment Reprogramming by Dexmedetomidine Treatment in Ischemic Stroke},
  journal = {Molecular Neurobiology},
  year = {2025},
  doi = {10.1007/s12035-025-05237-1}
}
Kostenlos starten →